|
Volumn 27, Issue 18, 2009, Pages 3064-
|
Cause-specific colostomy rates after chemoradiotherapy for anal carcinoma: Cancer-related versus treatment-related colostomy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
MITOMYCIN;
ANTINEOPLASTIC AGENT;
ANUS CANCER;
ANUS CARCINOMA;
ANUS SPHINCTER;
BRACHYTHERAPY;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CAUSE SPECIFIC SURVIVAL;
CLINICAL ASSESSMENT;
CLINICAL PROTOCOL;
COLOSTOMY;
COMPARATIVE STUDY;
DRUG EFFICACY;
EVENT FREE SURVIVAL;
HUMAN;
INTENSITY MODULATED RADIATION THERAPY;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
PROGNOSIS;
RADIATION DOSE;
RADIOCHEMOTHERAPY;
RISK FACTOR;
SURGICAL RISK;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUMOR VOLUME;
ANUS TUMOR;
MULTIMODALITY CANCER THERAPY;
NOTE;
RADIOTHERAPY;
ANTINEOPLASTIC AGENTS;
ANUS NEOPLASMS;
COLOSTOMY;
COMBINED MODALITY THERAPY;
HUMANS;
RADIOTHERAPY;
|
EID: 67649977050
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2009.22.8890 Document Type: Letter |
Times cited : (6)
|
References (3)
|